Martin Tremblay
Sr. Director, Chemistry, Infinity Pharmaceuticals
Infinity Pharmaceuticals Inc784 Memorial Drive
Cambridge , Massachusetts 02139
United States
Phone: 617-453-1268. Fax: 617-682-1418.
E-mail: Martin.Tremblay@infi.com.
https://www.linkedin.com/pub/martin-tremblay/4/a13/976
http://www.pubfacts.com/author/Martin+R+Tremblay
https://www.researchgate.net/profile/Martin_Tremblay3
View Larger Map INFINITY PHARMA
http://www.infi.com/contact-us/
Summary
Infinity
Pharmaceuticals, Inc.: Demonstrated organizational and scientific
leadership for the discovery and development of innovative drugs in
oncology and inflammation; Key player in the discovery and development
of saridegib (IPI-926)
Saridegib...........http://newdrugapprovals.org/2015/09/11/ipi-926-saridegib/
Eisai, Inc.: Synthesis of natural products-based libraries; Total synthesis of marine natural product laulimalide.
The Scripps Research Institute: Design and synthesis of haptens for the production of catalytic antibodies.
Université Laval: Solution and solid-phase synthesis of estrogen receptor antagonists and inhibitors of steroid biosynthesis
Saridegib...........http://newdrugapprovals.org/2015/09/11/ipi-926-saridegib/
Eisai, Inc.: Synthesis of natural products-based libraries; Total synthesis of marine natural product laulimalide.
The Scripps Research Institute: Design and synthesis of haptens for the production of catalytic antibodies.
Université Laval: Solution and solid-phase synthesis of estrogen receptor antagonists and inhibitors of steroid biosynthesis
Experience
Education
Infinity Pharmaceuticals, 784 Memorial Drive, Cambridge, Massachusetts 02139, United States
The mission of Infinity Pharmaceuticals, Inc. is to discover,
develop, and deliver to patients best-in-class medicines for the
treatment of difficult-to-treat diseases, with a strong focus in
oncology and inflammation.
Small molecule discovery and development capabilities
Infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation.
Strategic alliances
Building on its strengths in innovative small molecule drug discovery and development, Infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline.
Business and scientific expertise
The company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business and drug discovery and development.
Culture of Citizen-Ownership
Infinity’s culture and environment of Citizen-Ownership is as important as its technologies. Infinity works together as a community with the shared goal of bringing important new medicines to patients.
Small molecule discovery and development capabilities
Infinity’s programs arise from the integration of a broad range of research and development capabilities, including strengths in cancer biology, medicinal chemistry, clinical and translational medicine, and drug product process development and formulation.
Strategic alliances
Building on its strengths in innovative small molecule drug discovery and development, Infinity has established significant alliances with leading pharmaceutical and biotechnology companies to help realize the full potential of its product pipeline.
Business and scientific expertise
The company has assembled a team of passionate, committed, and innovative individuals who bring together their collective expertise in all areas of business and drug discovery and development.
Culture of Citizen-Ownership
Infinity’s culture and environment of Citizen-Ownership is as important as its technologies. Infinity works together as a community with the shared goal of bringing important new medicines to patients.
Specialties
Oncology, small molecule, fully integrated-
Website
http://www.infi.com
-
Industry
Pharmaceuticals
-
Type
Public Company
-
Headquarters
784 Memorial Drive Cambridge, MA United States -
Company Size
51-200 employees
-
Founded
2001
/////////
.svg/2000px-Delaware_in_United_States_(US48).svg.png)
.jpg)